Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 349

1.

Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.

Han KH, Kudo M, Ye SL, Choi JY, Poon RT, Seong J, Park JW, Ichida T, Chung JW, Chow P, Cheng AL.

Oncology. 2011;81 Suppl 1:158-64. doi: 10.1159/000333280. Epub 2011 Dec 22.

PMID:
22212951
2.

Treatment of intermediate/advanced hepatocellular carcinoma in the clinic: how can outcomes be improved?

Lencioni R, Chen XP, Dagher L, Venook AP.

Oncologist. 2010;15 Suppl 4:42-52. doi: 10.1634/theoncologist.2010-S4-42. Review.

3.

Treatment algorithm for intermediate and advanced stage hepatocellular carcinoma: Korea.

Choi JY.

Oncology. 2011;81 Suppl 1:141-7. doi: 10.1159/000333277. Epub 2011 Dec 22.

PMID:
22212948
4.

Updated treatment approach to hepatocellular carcinoma.

Llovet JM.

J Gastroenterol. 2005 Mar;40(3):225-35. Review.

PMID:
15830281
5.

Management of HCC.

de Lope CR, Tremosini S, Forner A, Reig M, Bruix J.

J Hepatol. 2012;56 Suppl 1:S75-87. doi: 10.1016/S0168-8278(12)60009-9. Review.

PMID:
22300468
6.

The intermediate hepatocellular carcinoma stage: Should treatment be expanded?

Piscaglia F, Bolondi L.

Dig Liver Dis. 2010 Jul;42 Suppl 3:S258-63. doi: 10.1016/S1590-8658(10)60514-2.

PMID:
20547312
7.

Current treatment strategy for hepatocellular carcinoma.

Ng KK, Poon RT.

Saudi Med J. 2007 Sep;28(9):1330-8. Review.

PMID:
17768455
8.

Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy.

Kudo M.

Oncology. 2008;75 Suppl 1:1-12. doi: 10.1159/000181865. Epub 2008 Dec 17. Review.

PMID:
19092266
9.

Hepatocellular carcinoma: an Asian perspective.

Teo EK, Fock KM.

Dig Dis. 2001;19(4):263-8. Review.

PMID:
11935085
10.

Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization.

Raoul JL, Sangro B, Forner A, Mazzaferro V, Piscaglia F, Bolondi L, Lencioni R.

Cancer Treat Rev. 2011 May;37(3):212-20. doi: 10.1016/j.ctrv.2010.07.006. Epub 2010 Aug 17. Review.

PMID:
20724077
11.

Transarterial chemoembolization in hepatocellular carcinoma treatment: Barcelona clinic liver cancer staging system.

Han K, Kim JH.

World J Gastroenterol. 2015 Sep 28;21(36):10327-35. doi: 10.3748/wjg.v21.i36.10327. Review.

12.

Management of hepatocellular carcinoma.

Yu AS, Keeffe EB.

Rev Gastroenterol Disord. 2003 Winter;3(1):8-24. Review.

PMID:
12684589
13.

A randomized controlled trial of hepatectomy with adjuvant transcatheter arterial chemoembolization versus hepatectomy alone for Stage III A hepatocellular carcinoma.

Zhong C, Guo RP, Li JQ, Shi M, Wei W, Chen MS, Zhang YQ.

J Cancer Res Clin Oncol. 2009 Oct;135(10):1437-45. doi: 10.1007/s00432-009-0588-2. Epub 2009 May 1.

PMID:
19408012
14.

Review article: the management of hepatocellular carcinoma.

Cabrera R, Nelson DR.

Aliment Pharmacol Ther. 2010 Feb 15;31(4):461-76. doi: 10.1111/j.1365-2036.2009.04200.x. Epub 2009 Nov 19. Review.

15.

Multidisciplinary management of nonresectable hepatocellular carcinoma.

Park HC, Seong J, Tanaka M, Zeng ZC, Lim HY, Guan S, Bae SH, Tak WY.

Oncology. 2011;81 Suppl 1:134-40. doi: 10.1159/000333276. Epub 2011 Dec 22.

PMID:
22212947
16.

Treatment of hepatocellular carcinoma.

Forner A, Hessheimer AJ, Isabel Real M, Bruix J.

Crit Rev Oncol Hematol. 2006 Nov;60(2):89-98. Epub 2006 Jul 24. Review.

PMID:
16860993
17.

An overview of evidence-based management of hepatocellular carcinoma: a meta-analysis.

Salhab M, Canelo R.

J Cancer Res Ther. 2011 Oct-Dec;7(4):463-75. doi: 10.4103/0973-1482.92023. Review.

18.

The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma.

Llovet JM, Fuster J, Bruix J; Barcelona-ClĂ­nic Liver Cancer Group..

Liver Transpl. 2004 Feb;10(2 Suppl 1):S115-20. Review.

19.

Advanced HCC: emerging molecular therapies.

Finn RS.

Minerva Gastroenterol Dietol. 2012 Mar;58(1):25-34. Review.

PMID:
22419002
20.

Current strategy for staging and treatment: the BCLC update and future prospects.

Forner A, Reig ME, de Lope CR, Bruix J.

Semin Liver Dis. 2010 Feb;30(1):61-74. doi: 10.1055/s-0030-1247133. Epub 2010 Feb 19. Review.

PMID:
20175034

Supplemental Content

Support Center